ctDNA as promising tool for the assessment of minimal residual disease (MRD) and the need of an adjuvant treatment in gastroesophageal adenocarcinoma

Piva, VM; De Grandis, MC; Zuin, IS; Angerilli, V; Nappo, F; Alfieri, R; Djaballah, SA; Murgioni, S; Bergamo, F; Fassan, M; Valmasoni, M; Lonardi, S

Lonardi, S (通讯作者),IRCCS, Med Oncol 3, Veneto Inst Oncol IOV, Via Gattamelata 64, I-35128 Padua, Italy.

UPDATES IN SURGERY, 2023; 75 (2): 305

Abstract

Gastroesophageal adenocarcinoma is a challenging disease due to its poor prognosis and the presence of few therapeutic options. For these reasons, it ......

Full Text Link